These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia. Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044 [TBL] [Abstract][Full Text] [Related]
26. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results. Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791 [TBL] [Abstract][Full Text] [Related]
27. A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia. Bishop JF; Joshua DE; Lowenthal RM; Kronenberg H; Whiteside MG; Cobcroft R; Dodds A; Wolf M; Manoharan A Aust N Z J Med; 1986 Feb; 16(1):48-51. PubMed ID: 3458446 [TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy for acute lymphocytic leukaemia in 25 adults. de Vries EG; Mulder NH; Houwen B; Haaxma-Reiche H Blut; 1982 Mar; 44(3):151-8. PubMed ID: 6952951 [TBL] [Abstract][Full Text] [Related]
29. Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults. Donohue SM; Boughton BJ Cancer Chemother Pharmacol; 1989; 23(6):401-2. PubMed ID: 2713963 [TBL] [Abstract][Full Text] [Related]
30. Randomized clinical trial of cystosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia. Lewis JP; Linman JW; Marshall GJ; Pajak TF; Bateman JR Cancer; 1977 Apr; 39(4):1387-96. PubMed ID: 322835 [TBL] [Abstract][Full Text] [Related]
31. High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults. Glucksberg H; Cheever MA; Farewell VT; Fefer A; Sale GE; Thomas ED Cancer; 1981 Sep; 48(5):1073-81. PubMed ID: 7023650 [TBL] [Abstract][Full Text] [Related]
32. Progress in acute myelogenous leukemia. Gale RP Cancer Treat Rep; 1981; 65 Suppl 4():87-92. PubMed ID: 7049383 [TBL] [Abstract][Full Text] [Related]
35. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia. Wiernik PH Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382 [No Abstract] [Full Text] [Related]
36. A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia. Cassileth PA; Begg CB; Bennett JM; Bozdech M; Kahn SB; Weiler C; Glick JH Blood; 1984 Apr; 63(4):843-7. PubMed ID: 6704545 [TBL] [Abstract][Full Text] [Related]
37. Intensive chemotherapy for acute myelogenous leukemia. Gale RP; Foon KA; Cline MJ; Zighelboim J Ann Intern Med; 1981 Jun; 94(6):753-7. PubMed ID: 6940466 [TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of treatment of acute myeloblastic leukemia in patients more than 55 years old. Barbui T; Bassan R; Chisesi T; Battista R; Cortelazzo S; Rodeghiero F; Capnist G; Viero P; D'Emilio A; Dini E Acta Haematol; 1982; 67(3):170-4. PubMed ID: 6805203 [No Abstract] [Full Text] [Related]
39. [Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures]. Link H; Frauer HM; Wilms K; Waller HD Klin Wochenschr; 1983 Apr; 61(7):329-38. PubMed ID: 6575217 [No Abstract] [Full Text] [Related]
40. Management of patients with acute non-lymphocytic leukemia who fail first cycle of induction therapy. Hasbrouck DJ; Peterson BA; Hurd DD; Bloomfield CD Leuk Res; 1981; 5(4-5):357-61. PubMed ID: 7289645 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]